News - Page 9

NB completes a licensing agreement with iPS Academia Japan, Inc. for induced pluripotent stem cell technologies

The agreement will enable Newcells to develop, manufacture, distribute products and offer services to customers in the pharmaceutical, biotechnology and academic sectors in Europe. Dr Mike Nicholds CEO of Newcells…